方达医药新闻资讯

Frontage Clinical Services, Inc. Expands Facilities to Accommodate Tobacco and Nicotine-Related Studies

Frontage Clinical Services, Inc. (“Frontage Clinical”), an associate of Frontage Laboratories, Inc. (“Frontage Labs”), is pleased to announce completion of renovations to Frontage Clinical’s center in Secaucus, New Jersey, to now accommodate clinical studies on tobacco and nicotine-containing products. This expansion highlights Frontage Clinical’s commitment to the investigation of the safety of new tobacco alternatives.

Frontage Laboratories, Inc., a wholly owned subsidiary of Frontage Holdings Corporation (HK.1521), has once again been named as a CRO Leadership Awards recipient by Life Science Leader magazine.

Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx

Frontage Holdings Corporation, the parent company of Frontage Laboratories, Inc., a fast-growing contract research organization, specializing in R&D product development services, with operations in both the United States and China, announced on May 30th that the Company's Shares have initiated trading on the Main Board of The Stock Exchange of Hong Kong

As Senior Vice President of Global Operations, Sridhar will be responsible for integrating business units and provide operational excellence leadership across the Frontage organization.

As Chief Financial Officer (CFO), Joe (Yifeng) Gao has the primary responsibility for planning, implementing, managing and controlling all financial-related activities for Frontage.

Frontage Sponsors the CABS workshop “Preclinical and Early Phase Development of Biologics and Small Molecules”

CABS workshop "Preclinical and Early Phase Development of Biologics and Small Molecules" sponsored by Frontage Laboratories, Inc., was successfully held on December 11th, 2018 at DoubleTree Hotel in Burlingame, California. The workshop featured four presentations by leading experts in areas of preclinical and early stage development of biologics and small molecule therapeutics and a lively panel discussion on hot topics and emerging trends in biologics and small molecule drug development.

Exton, PA, July 10, 2018: Frontage Laboratories, Inc. has been named as a 2018 CRO Leadership Awards recipient by Life Science Leader magazine. The publication annually asks pharmaceutical and biopharmaceutical companies to rate the capability and performance of contract research organizations.

Dr. Song Li Awarded Entrepreneur Of The Year®

Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Entrepreneur Of The Year®Award for 2018. 

Dr. Song Li Wins Healthcare CEO Enterprise Award

Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Healthcare CEO of the Year Enterprise Award for 2018.